, is pleased to announce that its Phase III clinical study called DIAMOND has completed the first batch of patient medications. To evaluate the effectiveness and safety of OCS-01 in the treatment of diabetic macular edema
Two styles a day! Hengrui Medicine's anesthetics and eye drops were approved for listing in China today
Time of Update: 2021-12-08
According to the public information disclosed by Hengrui Medicine, it is speculated that the new indication for the drug approved this time may be general anesthesia or bronchoscopy sedation .
The first eye drops for presbyopia has been approved
Time of Update: 2021-11-14
The press release stated that this is the first eye drop therapy approved by the FDA for the treatment of presbyopia .
Experts clarify the misunderstanding: single drop of eye drops can not cure dry eye
Time of Update: 2021-10-19
Momo (a pseudonym), who has been using eyes for a long time, bought a variety of eye drops and used it on his own, but the symptoms of dry and astringent eyes became more and more serious .
How difficult is it to withdraw the "magic drug" from Sharp's eye drops?
Time of Update: 2021-10-10
Four years ago, the "Doctor Dingxiang" public account released "A year of 750 million brainwashing drugs, please let go of the Chinese elderly", bombarding Sharp Aisi eye drops for over
Thyroid: Patients with Graves ophthalmopathy use prostaglandin F2-α eye drops (bimatoprost)
Time of Update: 2021-09-29
In inactive GO, treatment with bimatoprost for more than 3 months does not improve exophthalmos .
Precautions for sulfamethoxazole sodium eye drops
Time of Update: 2021-08-29
Sulfamethoxazole Sodium Eye Drops is a topical drop for treatment of bacterial conjunctivitis, stye and bacterial
Santian company VERKAZIA (0.1% cyclosporine eye drops) application for listing has been accepted
Time of Update: 2021-08-09
1% cyclosporine eye drops) is a cationic emulsion eye drops developed by Santian Company, suitable for the treatment of severe vernal keratoconjunctivitis (VKC) in children and adolescents 4 years and older .
Promising to be the first eye drops for the treatment of presbyopia, AbbVie's innovative treatment phase 3 clinical results are positive
Time of Update: 2021-07-27
Retrieved July 25, 2021, from https:// releases/new-data-presented-on-the-safety-and-efficacy-of-investigational-agn-190584-as-a-potential-novel-treatment-for-presbyopia-a-common-and-progressive-eye- condition-301339937.
Kelun Pharmaceutical: Moxifloxacin Hydrochloride Eye Drops Obtained Drug Registration Approval
Time of Update: 2021-07-09
On April 15th, Kelun Pharmaceutical issued an announcement stating that the chemical drug "Moxifloxacin Hydrochloride Eye Drops" of its subsidiary Jiangxi Kelun Pharmaceutical Co.
Qilu Pharmaceuticals" "Dkwa phosphorus sodium eye drops" the second newspaper listed
Time of Update: 2020-12-24
protein, and thus improve the symptoms of dry eye disease. the drug was developed with the authorization of Inspire Pharmaceuticals (Merck subsidiary) and was first approved in Japan in October 2010 for the treatment of dry eye disease under
Qilu is going to grab the first imitation again! The three major eye drops in the trial hit the 10 billion market
Time of Update: 2020-12-13
urban public hospitals, The market size of end ophthalmology drugs in county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) has exceeded 10 billion, with sales growth exceeding 10
Will the deadline go to cataract "god medicine" Shapps eye drops or will it be discontinued?
Time of Update: 2020-11-04
to the State Food and Drug Administration The notice document on the matter related to Shapps eye drops requires the company to "start clinical effectiveness trials as soon as possible in accordance with the relevant provisions of the Drug Administration
Eye performance for the treatment of cysteine deposition FDA approved the first cysteine eye drops.
Time of Update: 2020-09-28
We are pleased to bring Cystadrops products to patients in the United States, the first FDA-approved cysteine eye drops formula that is actually used four times a day to reduce corneal crystals.
Clinically in urgent need of new drugs! Cenegermin eye drops have been approved in China.
Time of Update: 2020-09-08
both trials studied Cenegermin Senegigmin eye drop monotherapy (20 μg/mL) in patients with moderate or severe neurotrophic corneitis and compared it with treatments without preservative artificial tear fluid-like epinoratives.